Studies on an (S)-2-amino-3-(3-hydroxy-5-methyl-4-isoxazolyl)propionic acid (AMPA) receptor antagonist IKM-159: asymmetric synthesis, neuroactivity, and structural characterization.

Studies on an (S)-2-amino-3-(3-hydroxy-5-methyl-4-isoxazolyl)propionic acid (AMPA) receptor antagonist IKM-159: asymmetric synthesis, neuroactivity, and structural characterization.
复制标题

DOI:
10.1021/jm301590z
复制
发表时间:
2013-03-28
影响因子:
7.3
通讯作者:
Oikawa, Masato
Oikawa, Masato
中科院分区:
医学1区
文献类型:
--
作者:
Juknaite, Lina;Sugamata, Yutaro;Tokiwa, Kazuya;Ishikawa, Yuichi;Takamizawa, Satoshi;Eng, Andrew;Sakai, Ryuichi;Pickering, Darryl S.;Frydenvang, Karla;Swanson, Geoffrey T.;Kastrup, Jette S.;Oikawa, Masato

文献摘要

参考文献

被引文献

相似文献

IKM-159被开发并鉴定为一类新的杂三环谷氨酸类似物的成员,其作为AMPA受体选择性拮抗剂。然而,尚不清楚IKM-159的哪种对映异构体负责其药理活性。在这里,我们报告在体内和体外的神经元活性的两个对映体的IKM-159制备的对映体的不对称合成。通过使用(R)-2-氨基-2-(4-甲氧基苯基)乙醇作为手性辅助剂,在总共18个步骤中成功地合成了(2 R)-IKM-159和(2S)-对应物,产率分别为0.70%和1.5%。行为和电生理学测定均表明,外消旋混合物观察到的生物活性仅用(2 R)-IKM-159再现,而(2S)-对应物在两种测定中均无活性。外消旋IKM-159与GluA 2的配体结合结构域一起结晶,结构显示在谷氨酸结合位点含有(2 R)-IKM-159的复合物。(2 R)-IKM-159以开放形式锁定GluA 2,与作为AMPA受体的竞争性拮抗剂的药理学作用一致。
IKM-159 was developed and identified as a member of a new class of heterotricyclic glutamate analogues that act as AMPA receptor-selective antagonists. However, it was not known which enantiomer of IKM-159 was responsible for its pharmacological activities. Here, we report in vivo and in vitro neuronal activities of both enantiomers of IKM-159 prepared by enantioselective asymmetric synthesis. By employment of (R)-2-amino-2-(4-methoxyphenyl)ethanol as a chiral auxiliary, (2R)-IKM-159 and the (2S)-counterpart were successfully synthesized in 0.70% and 1.5% yields, respectively, over a total of 18 steps. Both behavioral and electrophysiological assays showed that the biological activity observed for the racemic mixture was reproduced only with (2R)-IKM-159, whereas the (2S)-counterpart was inactive in both assays. Racemic IKM-159 was crystallized with the ligand-binding domain of GluA2, and the structure revealed a complex containing (2R)-IKM-159 at the glutamate binding site. (2R)-IKM-159 locks the GluA2 in an open form, consistent with a pharmacological action as competitive antagonist of AMPA receptors.
DOI: 10.1107/s0907444909029436
发表时间: 2009-10-01
影响因子: 2.2
作者:
Moriarty, Nigel W.;Grosse-Kunstleve, Ralf W.;Adams, Paul D.
通讯作者: Adams, Paul D.
DOI: 10.1038/sj.bjp.0705148
发表时间: 2003-03-01
影响因子: 7.3
作者:
More, JCA;Troop, HM;Jane, DE
通讯作者: Jane, DE
DOI: 10.1039/b311203a
发表时间: 2004-02-21
影响因子: 4.9
作者:
Kan, T;Fukuyama, T
通讯作者: Fukuyama, T
DOI: 10.1111/j.1476-5381.2010.00784.x
发表时间: 2010-07-01
影响因子: 7.3
作者:
Gill, M. B.;Frausto, S.;Swanson, G. T.
通讯作者: Swanson, G. T.
DOI: 10.1107/s0907444909052925
发表时间: 2010-02
期刊: Acta crystallographica. Section D, Biological crystallography
影响因子: --
作者:
Adams PD;Afonine PV;Bunkóczi G;Chen VB;Davis IW;Echols N;Headd JJ;Hung LW;Kapral GJ;Grosse-Kunstleve RW;McCoy AJ;Moriarty NW;Oeffner R;Read RJ;Richardson DC;Richardson JS;Terwilliger TC;Zwart PH
通讯作者: Zwart PH